96 related articles for article (PubMed ID: 1447748)
41. Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound.
Schlemmer R; Spruss T; Bernhardt G; Schönenberger H
Arch Pharm (Weinheim); 2001 Oct; 334(10):309-17. PubMed ID: 11759169
[TBL] [Abstract][Full Text] [Related]
42. Unprecedented monofunctional metalation of adenine nucleobase in guanine- and thymine-containing dinucleotide sequences by a cytotoxic platinum-acridine hybrid agent.
Barry CG; Baruah H; Bierbach U
J Am Chem Soc; 2003 Aug; 125(32):9629-37. PubMed ID: 12904029
[TBL] [Abstract][Full Text] [Related]
43. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
[TBL] [Abstract][Full Text] [Related]
44. [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II), a new drug not only parenterally but also orally active in the therapy of breast and prostate cancer.
Spruss T; Schertl S; Schneider MR; Gust R; Bauer K; Schönenberger H
J Cancer Res Clin Oncol; 1993; 119(12):707-16. PubMed ID: 8408183
[TBL] [Abstract][Full Text] [Related]
45. Dichloro(propane-1,3-diamine-kappa2N,N')platinum(II), dichloro(propane-1,3-diamine-kappa2N,N')palladium(II) and mu-4,9-diazadodecane-1,12-diamine-kappa2N1,N4:kappa2N9,N12-bis[dichloroplatinum(II)].
Odoko M; Okabe N
Acta Crystallogr C; 2006 Apr; 62(Pt 4):m136-9. PubMed ID: 16598121
[No Abstract] [Full Text] [Related]
46. Monofunctional platinum amine complexes destabilize DNA significantly.
Bauer C; Peleg-Shulman T; Gibson D; Wang AH
Eur J Biochem; 1998 Sep; 256(2):253-60. PubMed ID: 9760162
[TBL] [Abstract][Full Text] [Related]
47. Cellular uptake and toxicity study of cis-bis(6-aminoquinoline) dichloroplatinum (II).
Lu MQ; Chang JC; Bergquist BL
J Inorg Biochem; 1991 Jun; 42(4):231-5. PubMed ID: 1880504
[TBL] [Abstract][Full Text] [Related]
48. A surprisingly stable macrochelate formed from the reaction of cis dinuclear platinum antitumor compounds with reduced glutathione.
Oehlsen ME; Hegmans A; Qu Y; Farrell N
Inorg Chem; 2005 May; 44(9):3004-6. PubMed ID: 15847402
[TBL] [Abstract][Full Text] [Related]
49. Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.
Deqnah N; Yu JQ; Beale P; Fisher K; Huq F
Anticancer Res; 2012 Jan; 32(1):135-40. PubMed ID: 22213298
[TBL] [Abstract][Full Text] [Related]
50. Biophysical analysis of natural, double-helical DNA modified by a dinuclear platinum(II) organometallic compound in a cell-free medium.
Marini V; Kasparkova J; Novakova O; Monsú Scolaro L; Romeo R; Brabec V
J Biol Inorg Chem; 2002 Sep; 7(7-8):725-34. PubMed ID: 12203009
[TBL] [Abstract][Full Text] [Related]
51. Preparation of platinum(IV) complexes with dipeptide and diimine. X-ray crystal structure and 195Pt NMR spectra.
Watabe M; Fukuda H; Kitsukawa K; Nakajima H; Yukawa Y; Igarashi S; Fujii Y; Takayama T
J Inorg Biochem; 2006 Oct; 100(10):1653-9. PubMed ID: 16857262
[TBL] [Abstract][Full Text] [Related]
52. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
[TBL] [Abstract][Full Text] [Related]
53. Thermodynamic and kinetic studies on reactions of Pt(II) complexes with biologically relevant nucleophiles.
Summa N; Schiessl W; Puchta R; van Eikema Hommes N; van Eldik R
Inorg Chem; 2006 Apr; 45(7):2948-59. PubMed ID: 16562950
[TBL] [Abstract][Full Text] [Related]
54. Radiosensitization of EMT6 cells by four platinum complexes.
Teicher BA; Rockwell S; Lee JB
Int J Radiat Oncol Biol Phys; 1985 May; 11(5):937-41. PubMed ID: 4039304
[TBL] [Abstract][Full Text] [Related]
55. Uptake and metabolism of iproplatin in murine L1210 cells.
Pendyala L; Walsh JR; Huq MM; Arakali AV; Cowens JW; Creaven PJ
Cancer Chemother Pharmacol; 1989; 25(1):15-8. PubMed ID: 2590997
[TBL] [Abstract][Full Text] [Related]
56. Anticancer drugs: estrophilic cisplatin derivatives.
Engel J; Schönenberger H; Lux F; Hilgard P
Cancer Treat Rev; 1987 Dec; 14(3-4):275-83. PubMed ID: 2830970
[TBL] [Abstract][Full Text] [Related]
57. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
58. Determination of cisplatin and some possible metabolites by ion-pairing chromatography with inductively coupled plasma mass spectrometric detection.
Zhao Z; Tepperman K; Dorsey JG; Elder RC
J Chromatogr; 1993 May; 615(1):83-9. PubMed ID: 8340466
[TBL] [Abstract][Full Text] [Related]
59. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
Sharp SY; Rogers PM; Kelland LR
Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
[TBL] [Abstract][Full Text] [Related]
60. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
